Searched for
SHEKHAR C MANDE
Policy to come in 7-8 days to promote private sector R&D in railways: Ashwini VaishnawVaishnaw, who also handles the telecom and IT ministry, appreciated industry suggestions on the spectrum management and called for action f...
Neglected infectious diseases may be tomorrow's pandemic: Bharat Biotech chief Dr Krishna EllaBharat Biotech's Covaxin is credited to be India's first indigenous COVID-19 vaccine to be approved and administered to a sizeable populati...
CSIR, Tata MD partner to ramp up Covid testing capacity across tier 2, 3 towns and rural areasThe initiative will utilise CSIR's network of labs across India and help increase testing capacity in smaller locations in the country. The...
Bharat Biotech, Biovet, Sapigen Biologix sign collaborative research agreement with CSIR-IICTThe Master Collaborative Agreement (MCA) was signed here by Bharat Biotech International, Biovet, Sapigen Biologix with the IICT in the pre...
COVID-19 crisis far from over; 3rd wave to be more dangerous: CSIR officialContinued collaboration across institutions was necessary to come out of the current situation as well as ward off catastrophic situations ...
Cipla all set to launch Favipiravir drug for treatment of COVID patients: CSIRAn off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatme...
Airborne transmission of Covid possible, wear masks in enclosed spaces, cautions CSIRAmid recent acknowledgement from the World Health Organisation (WHO) over emerging evidence of airborne spread of the novel coronavirus, th...
'Feluda': Made-in-India paper-based strip for rapid, mass testing for Covid-19A completely indigenous scientific invention, 'Feluda' has been designed for mitigating the ongoing Covid-19 situation and to cater to mass...
CSIR lab, TaTa Sons sign MoU for licensing for COVID-19 knowhowThe license shall include transfer of the knowledge for scaling up the KNOWHOW in the form of a kit that can be deployed for COVID-19 testi...
Time to give our best shot: Health MinistryWith no vaccine in sight, India has resorted to pharmacological interventions like aggressive testing, isolation and contact-tracing, apart...
Genome sequencing: A solution to India's problem of rare genetic diseasesA genome is a person’s complete set of DNA, including all genes with more than 3 billion DNA base pairs. Genome sequencing will lead to pre...
Patents crucial for India to bridge tech gap with US and ChinaIndia spent just 0.7% of its GDP in 2016-17 on R&D. Japan, US and China spent 3.2%, 2.8% and 2.1%.